Kaliumjodid Serb

Potassium Iodide, the active ingredient in Kaliumjodid Serb, is an iodine compound presented as an oral preparation for oral use. It is employed to protect the thyroid gland during exposure to radioactive iodine and to prevent iodine deficiency in emergency situations.\n\nGNH India supplies Kaliumjodid Serb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kaliumjodid Serb is an iodine compound used in thyroid‑related emergency and deficiency contexts.\n\n- Radiation emergency prophylaxis: Provides thyroid protection during exposure to radioactive iodine.\n- Iodine deficiency prevention: Supplies stable iodide to avert deficiency in populations affected by emergencies.\n- Thyroid protection in nuclear incidents: Reduces uptake of radioactive iodine by the thyroid, minimizing radiation‑induced damage.

Potassium Iodide may cause a range of adverse reactions, from mild to severe.\n\nCommon Side Effects:\n- Metallic taste in the mouth.\n- Nausea or mild gastrointestinal upset.\n- Headache or mild dizziness.\n- Skin rash or itching.\n- Mild swelling of the salivary glands.\n\nSerious or Rare Side Effects:\n- Anaphylactic or severe allergic reaction.\n- Significant thyroid dysfunction (hyperthyroidism or hypothyroidism).\n- Swelling of the face, lips, tongue, or throat.\n- Persistent vomiting or diarrhea leading to dehydration.

When using Kaliumjodid Serb, several safety considerations should be observed.\n\n- Assess iodine status: Verify baseline iodine levels before administration.\n- Allergy screening: Avoid in individuals with known iodine or potassium iodide allergy.\n- Thyroid disorders: Use cautiously in patients with existing hyperthyroidism or hypothyroidism.\n- Pregnancy and lactation: Evaluate risk‑benefit ratio; consult a healthcare professional.\n- Dosage adherence: Do not exceed the prescriber‑specified amount.\n- Store at room temperature: Keep in the original packaging, protect from moisture and direct sunlight.

Potassium Iodide can interact with several medications, requiring attention to avoid reduced efficacy or increased toxicity.\n\nMajor Interactions (Avoid):\n- Levothyroxine therapy: May diminish thyroid hormone absorption.\n- Antithyroid drugs (propylthiouracil, methimazole): Reduce protective effect of iodide.\n- Lithium: Can exacerbate thyroid dysfunction when combined.\n\nModerate Interactions (Monitor Closely):\n- Diuretics (especially thiazides): May alter potassium balance.\n- ACE inhibitors: Potential for altered renal handling of iodide.\n- Amiodarone: Increases overall iodine load, affecting thyroid function.\n- Radioactive iodine therapy: May interfere with intended therapeutic uptake.